Research summary
Research summary
04/03/2024

Jessica Ganga

Jessica Ganga
The US Preventive Services Task Force (USPSTF) conducted a systematic review to determine the potential benefits and harms to screening and interventions for oral health conditions in adults.
04/03/2024
Research Summary
Research Summary
03/13/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
03/13/2024
Research Summary
Research Summary
02/28/2024

Jessica Ganga

Jessica Ganga
Researchers found that the current recommendations for vitamin D intake in individuals are not enough for patients to reach optimal vitamin D levels.
02/28/2024
Research Summary
Research Summary
02/15/2024
Anthony Calabro, MA
The CDC reported more than 200,000 cases of syphilis in 2022, a 17% increase compared with the previous year. In response, the CDC provided new recommendations for testing syphilis in the laboratory.
02/15/2024
Roundtable Wrap-Up
Roundtable Wrap-Up
01/12/2024
Carol Wysham, MD; Hope Warshaw, RD; Eugene E. Wright, Jr., MD
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing people with diabetes, the importance of diabetes self-care and...
01/12/2024
Research Summary
Research Summary
10/24/2023
Jessica Ganga
In a placebo-controlled, randomized trial, researchers tested the efficacy of cytisinicline—a smoking cessation medication—for those who would like to quit smoking.
10/24/2023
Research Summary
Research Summary
10/13/2023
Jessica Ganga
In a double-blinded, randomized study, a team of researchers evaluated the safety and efficacy of the use of toothpaste containing hydroxyapatite.
10/13/2023
FDA Alert
FDA Alert
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA Alert
FDA Alert
09/15/2023
Anthony Calabro, MA
The FDA approved the new round of vaccines for those 12 years and older and authorized emergency use for children 6 months to 11 years of age.
09/15/2023
FDA Alert
FDA Alert
08/24/2023
Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023